Regulatory Compliance

Lytx Webinar Tackles Broker Liability Fallout From Supreme Court Ruling

Image
Lytx Webinar Tackles Broker Liability Fallout From Supreme Court Ruling

San Diego – October 06, 2026 -- Lytx Inc. will host a live webinar on Oct. 27 examining how the Supreme Court's unanimous ruling in Montgomery v. Caribe Transport II is reshaping broker-carrier relationships by exposing brokers to state-law negligent-selection claims.

Supreme Court ruling opens brokers to new liability exposure

The decision in Montgomery v. Caribe Transport II allows brokers to face state-law claims tied to negligent carrier selection, prompting brokers to tighten how they vet and retain carriers. Fleets may now face heightened scrutiny of safety records, public inspection data and compliance documentation as brokers reassess approval criteria.

Picarro's AMLD Tech Detects 100% of Methane Leaks in DVGW Field Test

Image
Picarro's AMLD Tech Detects 100% of Methane Leaks in DVGW Field Test

Santa Clara – October 06, 2026 -- Picarro, Inc. achieved a 100% detection rate for methane leaks during real-world field testing conducted under the DVGW-funded Fahrzeuggestützte Methanmessung (FaMeGQ) research project in Germany, the only system among six vehicle-based technologies evaluated to detect all 10 methane events presented during live-network validation.

Picarro detects all 10 methane events in Regensburg field trial

During testing on roughly 50 kilometers of active gas distribution network in Regensburg, Picarro's Advanced Mobile Leak Detection (AMLD) system identified all eight controlled methane releases installed for the evaluation, plus two additional, previously unknown leaks that were later independently confirmed. No other participating system matched this result.

Checkr Expands Mortgage Verification After Truv Acquisition, Workday Deal

Image
Checkr Expands Mortgage Verification After Truv Acquisition, Workday Deal

San Francisco – October 06, 2026 -- Checkr has expanded its mortgage verification offering to cover more than 97% of U.S. workers with a 75% completion rate, adding new data sources as borrower income grows increasingly volatile.

Income instability among mortgage applicants rose to 62% in 2025 from 50% in 2022

Truework's 2026 housing affordability research, based on roughly 300,000 mortgage applicant records, found the share of applicants with unstable income climbed to 62% in 2025, up from 50% in 2022. The severity of income swings nearly tripled over the same period, according to the study.

Strider Secures $85M Air Force Deal to Screen SBIR Applicants

Image
Strider Secures $85M Air Force Deal to Screen SBIR Applicants

Washington – October 06, 2026 -- Strider Technologies has secured a contract worth up to $85 million from the Department of the Air Force, formalizing a five-year collaboration with the service's Office of Commercial and Economic Analysis (OCEA) to screen for nation-state risk in defense innovation programs.

Contract formalizes existing screening work on federal small-business funding programs

The agreement builds on Strider's prior work with OCEA and covers continued screening of applicants to the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These programs direct federal R&D funding to small U.S. businesses developing technologies with both defense and commercial applications, making them a target for adversarial nation-states seeking sensitive technology, intellectual property, and talent through undisclosed foreign ties, ownership, or financing.

AHRQ Launches $11.8M Challenge to Boost Healthcare Competition

Rockville, Md. – October 06, 2026 -- The Agency for Healthcare Research and Quality (AHRQ) has launched its largest-ever market reform research challenge, offering up to $11.8 million to fund solutions that lower healthcare costs and expand patient choice.

AHRQ ties challenge launch to $556.6 billion in out-of-pocket costs

The agency cited Centers for Medicare & Medicaid Services data showing Americans spent a combined $556.6 billion in out-of-pocket healthcare expenses in 2024. A March 2026 KFF analysis found that one or two health systems controlled the entire inpatient hospital care market in nearly half of U.S. metropolitan areas that year, with concentration exceeding 75% market share in 83% of metro areas.

Borouge International Secures RC14001, ISO 14001 Certification in Canada

Image
Borouge International Secures RC14001, ISO 14001 Certification in Canada

Calgary – October 06, 2026 -- Borouge International, operating under NOVA Chemicals in North America, has achieved RC14001:2023 and ISO 14001:2015 certifications across its Canadian manufacturing sites, research centres and administration functions.

Canadian operations align with global HSE standard first adopted in 2017

The company began its RC14001 implementation journey in 2017, building the management system as a cross-functional, enterprise-wide effort. The certification confirms that environmental, health, safety and security management across the Canadian footprint now meets ISO 14001 and Responsible Care (RC)® principles.

Geismar facility served as the certification model, recertified twice since 2020

The Canadian certification builds on the earlier success of Borouge International's Geismar facility, which was first certified under the same standard in 2020 and has since been recertified twice.

Nanoscope to Present 4-Year RP Data, Dry AMD Poster at AAO 2026

Image
Nanoscope to Present 4-Year RP Data, Dry AMD Poster at AAO 2026

Dallas – October 06, 2026 -- Nanoscope Therapeutics will present four-year durability data from its RESTORE Phase 2b/3 trial of optogenetic therapy MCO-010 in retinitis pigmentosa at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, running October 8–13 in New Orleans.

Four-year REMAIN data to show durability of vision gains in retinitis pigmentosa

Dr. Kenneth C. Fan will present the REMAIN study results on Sunday, October 11, highlighting sustained vision improvement among patients treated with MCO-010 in the RESTORE trial. A separate scientific poster from Dr. David S. Boyer will detail vision improvement with sonpiretigene isteparvovec in dry age-related macular degeneration, drawn from what the company describes as the first direct-to-Phase 2 randomized controlled trial in that indication.

Veeva DQS Cleans Data for 1M+ Trial Subjects, Cuts Manual Work

Image
Veeva DQS Cleans Data for 1M+ Trial Subjects, Cuts Manual Work

Barcelona – October 06, 2026 -- Veeva Systems (NYSE: VEEV) said its Data Quality System (DQS) has aggregated and cleaned data for more than 1 million subjects across over 1,000 clinical studies, automating over 500,000 queries and eliminating thousands of hours of manual data reconciliation for sites and sponsors.

Veeva DQS automates over 500,000 queries to speed analysis-ready data delivery

The platform classifies and visualizes critical trial data while orchestrating risk-based actions across the clinical ecosystem, removing manual reconciliation steps that have historically slowed data lock and submission timelines.

Novo cites rising trial data volume as key driver for automated data management

Ibrahim Kamstrup-Akkaoui, vice president at Novo, said managing data from a growing number of clinical trials is a priority, and that Veeva DQS helps the company manage, format, clean, and prepare data for submission more efficiently.

Viking Launches Phase 2 Study of Oral VK2735 Maintenance Dosing

Image
Viking Launches Phase 2 Study of Oral VK2735 Maintenance Dosing

San Diego – October 06, 2026 -- Viking Therapeutics (NASDAQ: VKTX) has initiated Part 2 of a maintenance dosing study for VK2735, its dual GLP-1/GIP receptor agonist, testing oral tablet regimens alongside subcutaneous options to sustain weight loss after initial treatment.

Trial enrolls 195 obese adults to test five maintenance pathways

The randomized, double-blind, placebo-controlled study will enroll approximately 195 adults with obesity (BMI ≥30 kg/m2). All participants first receive 21 weeks of weekly subcutaneous VK2735 or placebo before transitioning to one of five maintenance arms: daily oral doses, weekly oral doses, monthly subcutaneous doses, every-other-week subcutaneous doses, or placebo. The study runs through Week 33, tracking safety, tolerability, pharmacokinetics, and body weight change from baseline and from Week 21.

Seasoft Identity Launches Automated User Access Reviews

Image
Seasoft Identity Launches Automated User Access Reviews

Garden City, N.Y. – October 06, 2026 -- Seasoft Solutions has launched User Access Reviews (UAR) for its Seasoft Identity platform, combining automated access certification and remediation into a single workflow for mid-market organizations.

Platform replaces spreadsheet-based certification with automated campaigns

IT and security teams can now define which systems and applications require certification, assign reviewers, and have Seasoft Identity automatically assemble review campaigns from existing platform access data. The tool eliminates manual exports, email follow-up, and separate remediation tracking that traditionally burden access certification cycles.